For clients who've plateaued on tirzepatide or semaglutide, the most evidence-based next stage in 2026 is optimizing the current protocol. Adjusting dose timing, revisiting macronutrient distribution, or incorporating resistance coaching to preserve lean mass during ongoing weight loss.Retatrutide for that therapy of weight problems, obstructive sl